TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+14.41%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.85B
AUM Growth
+$2.85B
(+6.6%)
Cap. Flow
-$35.8M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.19%
Holding
216
New
12
Increased
41
Reduced
45
Closed
16
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$45.7M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$36.7M |
| 3 |
Danaher
DHR
|
$33.8M |
| 4 |
Neurocrine Biosciences
NBIX
|
$22.1M |
| 5 |
DexCom
DXCM
|
$20.7M |
Top Sells
| 1 |
Amgen
AMGN
|
$44.1M |
| 2 |
Merck
MRK
|
$40.6M |
| 3 |
Pfizer
PFE
|
$36.5M |
| 4 |
AbbVie
ABBV
|
$27.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$22.7M |
Sector Composition
| 1 | Healthcare | 95.34% |
| 2 | Real Estate | 2.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Omega Healthcare
OHI
$12.6B
| $11.1M | 0.39% | 306,433 | – | – |
|
77
Ionis Pharmaceuticals
IONS
$6.79B
| $10.9M | 0.38% | 193,201 | – | – |
|
|
GRTX
78
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $10.7M | 0.37% | 1,041,845 | – | – |
|
79
Genmab
GMAB
$15.3B
| $10.5M | 0.37% | 258,672 +73,893 | +40% | +$3M |
|
80
Ventas
VTR
$30.9B
| $10.2M | 0.36% | 208,108 | – | – |
|
81
Arrowhead Research
ARWR
$3.05B
| $10.2M | 0.36% | 132,886 +58,700 | +79% | +$4.5M |
|
82
United Therapeutics
UTHR
$13.8B
| $9.64M | 0.34% | 63,513 | – | – |
|
83
Amicus Therapeutics
FOLD
$2.34B
| $9.37M | 0.33% | 405,626 | – | – |
|
84
Zoetis
ZTS
$69.3B
| $9.35M | 0.33% | 56,521 | – | – |
|
85
Medical Properties Trust
MPW
$2.7B
| $8.97M | 0.32% | 411,743 | – | – |
|
|
CCXI
86
DELISTED
ChemoCentryx, Inc.
CCXI
| $8.94M | 0.31% | 144,447 | – | – |
|
87
Kura Oncology
KURA
$686M
| $8.93M | 0.31% | 273,463 +214,124 | +361% | +$6.99M |
|
88
Sabra Healthcare REIT
SBRA
$4.58B
| $8.87M | 0.31% | 510,660 | – | – |
|
89
Boston Scientific
BSX
$156B
| $8.85M | 0.31% | 246,089 -495,207 | -67% | -$17.8M |
|
|
DOC
90
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $8.82M | 0.31% | 495,733 | – | – |
|
|
KRTX
91
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $8.66M | 0.3% | 85,236 +43,409 | +104% | +$4.41M |
|
92
Novavax
NVAX
$1.21B
| $8.54M | 0.3% | 76,585 +65,062 | +565% | +$7.26M |
|
93
Molina Healthcare
MOH
$9.8B
| $8.46M | 0.3% | 39,769 -2,900 | -7% | -$617K |
|
94
Exact Sciences
EXAS
$8.98B
| $8.41M | 0.3% | 63,502 +48,352 | +319% | +$6.41M |
|
95
Incyte
INCY
$16.5B
| $8.11M | 0.29% | 93,257 -59,348 | -39% | -$5.16M |
|
96
Theravance Biopharma
TBPH
$699M
| $8.11M | 0.28% | 456,296 +157,826 | +53% | +$2.8M |
|
|
ONC
97
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $7.31M | 0.26% | 28,280 | – | – |
|
98
FibroGen
FGEN
$47.8M
| $7.21M | 0.25% | 194,270 | – | – |
|
99
Owens & Minor
OMI
$378M
| $7.2M | 0.25% | +266,023 | New | +$7.2M |
|
|
LTC
100
LTC Properties
LTC
$1.68B
| $7.09M | 0.25% | 182,293 | – | – |
|